<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             DNA Repair (Amst). 2012 February 1; 11(2): 167&#226;&#8364;&#8220;176. doi:10.1016/j.dnarep.2011.10.016. <br />  <br />  <br />  <br />                            TAp63&#206;&#179; enhances nucleotide excision repair through <br />                            transcriptional regulation DNA repair genes <br />                            Juan Liu, Meihua Lin, Cen Zhang, Duoduo Wang, Zhaohui Feng, Wenwei Hu* <br />                            Cancer Institute New Jersey, University Medicine Dentistry New Jersey, New <br />                            Brunswick, NJ 08903, USA <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                 p63 p73, p53 family members, play crucial roles development tumor suppression. <br />                                 p63 p73 multiple isoforms, similar distinct biological functions. <br />                                 Transactivation (TA) isoforms p63 p73 high similarity p53 have <br />                                 biological functions similar p53. p53 plays important role nucleotide excision repair <br />                                 (NER) transcriptional regulation target genes involved NER, including DDB2, XPC <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 GADD45. <span id='am-3' about='protege:TO' typeof='owl:Thing'>To</span> investigate TAp63 TAp73 play similar role NER, Saos2 cells <br />                                 inducible expression specific isoforms TAp63 TAp73, including TAp63&#206;&#177;/&#206;&#178;/&#206;&#179; and <br />                                 TAp73&#206;&#177;/&#206;&#178;/&#206;&#179; isoforms, employed. Overexpression TAp63&#206;&#179; significantly enhances NER <br />                                 ultraviolet (UV)-induced DNA damage, including cyclobutane pyrimidine dimers (CPDs) and <br />                                 6&#226;&#8364;&#8220;4 photoproducts, enhances cell <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span>survival</span> UV irradiation Soas2 cells. The <br />                                 enhancement NER UV-induced DNA damage TAp63&#206;&#179; confirmed H1299 <br />                                 cells overexpression TAp63&#206;&#179;. Consistently, knockdown endogenous TAp63 decreases <br />                                 NER UV-induced DNA damage H1299 cells. TAp63&#206;&#177;/&#206;&#178; TAp73&#206;&#177;/&#206;&#178;/&#206;&#179; isoforms not <br />                                 clear effect NER Saos2 H1299 cells. TAp63&#206;&#179; overexpression clearly induces the <br />                                 expression DDB2, XPC GADD45 RNA protein levels. Furthermore, luciferase <br />                                 reporter assays TAp63&#206;&#179; transcriptionally activates DDB2, XPC GADD45 genes <br />                                 regulation p53 binding elements genes. These results demonstrate that <br />                                 TAp63&#206;&#179; enhances NER remove UV-induced DNA damage maintain genomic stability <br />                                 transcriptional induction set NER proteins, provides additional important <br />                                 mechanism contributes function TAp63 tumor suppression. <br />  <br />  <br />                            Keywords <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 p63; Isoforms; Nucleotide excision repair; Ultraviolet <br />  <br />  <br />                            1. Introduction <br />                                             p63 p73 structural functional homologs tumor suppressor p53. These <br />                                             family members transcription factor similar domain organization, all <br />                                             contain transactivation (TA) domain, prolin-rich (PR) domain, DNA binding domain <br />                                             (DBD) oligomerization domain (OD) (Fig. 1A) [1]. p53, p63 p73 share high <br />                                             similarity DBD, binds similar identical DNA sequences [2]. p63 p73 can <br />                                             transcriptionally regulate group p53-target genes, turn exert functions <br />                                             similar p53, including cell cycle arrest, apoptosis, cellular senescence response to <br />                                             stress. <br />  <br />  <br />                            &#194;&#169; 2011 Elsevier B.V. All rights reserved. <br />                            * <br />                              Corresponding author. Tel.: +1 732 235 6169. huw1@umdnj.edu (W. Hu). <br />                             Liu et al.                                                                                           Page 2 <br />  <br />  <br />                                         p63 p73 multiple isoforms diverse properties presence of <br />                                         alternative promoters alternative splicing carboxy-terminal end [3&#226;&#8364;&#8220;7]. Each gene <br />                                         promoters: promoter upstream exon 1 generates TA isoforms, an <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         alternative promoter intron 3 leads expression amino-terminally truncated <br />                                         (&#206;&#8221;N) isoforms lack TA domain. TAp63 TAp73 transcriptionally proficient, <br />                                         biological functions similar p53. &#206;&#8221;N isoforms usually transcriptionally <br />                                         inactive, function dominant negative inhibitors TAp53, TAp63 TAp73 <br />                                         repressing transactivation TA isoforms competing binding elements in <br />                                         target genes. Alternative splicing carboxy-terminal gives rise main <br />                                         isoforms p63 p73 (&#206;&#177;, &#206;&#178;, &#206;&#179;). Isoforms differ carboxy-terminal end have <br />                                         different abilities transactivate gene expression, turn functions common <br />                                         functions unique isoforms [8]. <br />  <br />                                         p63 p73 long suggested involved tumor suppression. However, their <br />                                         precise roles tumor suppression understood structure complexity <br />                                         existence multiple isoforms. TA isoforms suggested function as <br />                                         tumor suppressors &#206;&#8221;N isoforms function oncogenes. It shown p63 <br />                                         p73 induce cell cycle arrest, apoptosis senescence response stress. A recent <br />                                         study reported p63 p73 play role DNA repair [9]. DNA repair pathways, <br />                                         include nucleotide excision repair (NER), <span id='am-238' about='xsp:base' typeof='owl:Thing'>base</span> excision repair, double strand break <br />                                         (DBS) repair mismatch repair, play critical role maintaining genomic integrity and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         tumor prevention. p63 p73 shown transcriptionally induce genes <br />                                         involved homologous recombination repair DSBs, including BRCA2 Rad51. <br />                                         Mouse embryonic fibroblasts deficient p63 p73 impaired repair <br />                                         capacity DSBs [9]. <br />  <br />                                         NER major DNA repair mammalian cells, removes types of <br />                                         bulky DNA lesions induced environmental carcinogens, UV irradiation, and <br />                                         chemotherapeutic agents. The primary DNA lesions induced UV cyclobutane <br />                                         pyrimidine dimers (CPDs) 6&#226;&#8364;&#8220;4 photoproducts (6&#226;&#8364;&#8220;4 PPs), repaired by <br />                                         NER. Mutations defects human NER proteins result xeroderma pigmentosum (XP) <br />                                         syndrome. XP patients highly sensitive UV irradiation dramatically <br />                                         increased risk UV-associated skin cancer. It known p53 regulates NER <br />                                         [10]. The p53 deficient cells deficient NER CPD. As transcriptional factor, p53 <br />                                         regulates NER transcriptional activation genes involved NER, including <br />                                         DDB2, XPC, GADD45. The role p63 p73 NER understood. <br />                                         Considering structural functional similarity p53 TA isoforms p63 p73, <br />                                         TAp63 TAp73 transcriptionally regulate NER genes regulated p53 <br />                                         involved NER. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         To test possibility, impact TAp63 TAp73 isoforms NER the <br />                                         transcriptional regulation p53-regulated DNA repair genes, including DDB2, XPC and <br />                                         GADD45, determined Saos2 cells inducible specific TAp63 TAp73 <br />                                         isoforms. Saos2 cells deficient p53, p63 p73 [11]. Overexpression TAp63&#206;&#179; in <br />                                         cells clearly enhances NER UV-induced DNA damage, TAp63&#206;&#177;/&#206;&#178; TAp73&#206;&#177;/ <br />                                         &#206;&#178;/&#206;&#179; isoforms clear effect NER. TAp63&#206;&#179; enhances <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span>cell survival</span> after <br />                                         UV irradiation. Furthermore, TAp63&#206;&#179; displays strong transcriptional induction DDB2, <br />                                         XPC GADD45 mRNA protein levels, TAp63&#206;&#177;/&#206;&#178; TAp73&#206;&#177;/&#206;&#178;/&#206;&#179; <br />                                         isoforms limited induction genes. Luciferase reporter assays <br />                                         demonstrate TAp63&#206;&#179; transcriptionally activates DDB2, XPC GADD45 genes <br />                                         regulation p53 binding elements genes. Together, results <br />                                         clearly demonstrate TAp63&#206;&#179; plays important role NER transcriptional <br />                                         regulation group genes involved NER. <br />  <br />  <br />                                         DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                               Page 3 <br />  <br />  <br />                                2. Materials methods <br />                                2.1. Cell culture UV irradiation <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Saos2 cells Tet-on inducible expression TAp63&#206;&#177;, TAp63&#206;&#178;, TAp63&#206;&#179; TAp73&#206;&#177;, <br />                                             TAp73&#206;&#178;, TAp73&#206;&#179; (Saos2-TAp63&#206;&#177;, Saos2-TAp63&#206;&#178;, Saos2-TAp63&#206;&#179;, Saos2-TAp73&#206;&#177;, <br />                                             Saos2-TAp73&#206;&#178;, Saos2-TAp73&#206;&#179;) generous gifts Dr. Gerry Melino (University <br />                                             Rome &#226;&#8364;&#339;Tor Vergata&#226;&#8364;?, Italy). Cells grown 1:1 mixture Dulbecco&#226;&#8364;&#8482;s Minimal <br />                                             Essential Medium/F12 supplemented 10% fetal bovine serum 5% CO2 humidified <br />                                             incubator. The expression TAp73 TAp63 isoforms induced doxy-cycline <br />                                             (Dox) (2 &#206;&#188;g/ml). The human lung epithelial H1299 cells (ATCC) cultured in <br />                                             Dulbecco&#226;&#8364;&#8482;s modified Eagle&#226;&#8364;&#8482;s medium supplemented 10% fetal bovine serum. For UV <br />                                             irradiation, cells grown 50&#226;&#8364;&#8220;70% confluence irradiated various doses UV a <br />                                             fluency rate 1 J/m2/s using GE15118 germicidal lamp (predominate emission, 254 nm). <br />  <br />                                2.2. Quantitation repair CPD 6&#226;&#8364;&#8220;4 PP ELISA assays <br />                                             The removal CPD 6&#226;&#8364;&#8220;4 PP genomic DNA measured cellular UV DNA- <br />                                             damage detection kit CPD (Cyclex) OxiSelect cellular UV-induced DNA damage <br />                                             ELISA kit 6&#226;&#8364;&#8220;4 PP (Cell Biolabs), respectively, according manufacture&#226;&#8364;&#8482;s <br />                                             instructions. In brief, cells cultured Dox (2 &#206;&#188;g/ml) 24 h UV <br />                                             irradiated. The repair CPD 6&#226;&#8364;&#8220;4 PP determined different time points UV <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             irradiation. Genomic DNA denatured fixing/denaturing solution, incubated <br />                                             blocking solution avoid non-specific antibody binding. The samples then <br />                                             incubated anti-CPD anti-6&#226;&#8364;&#8220;4 PP antibody, respectively, followed HPR- <br />                                             conjugated secondary antibody. The substrate solution added absorbance 450 nm <br />                                             measured using microplate reader. <br />  <br />                                2.3. Host cell reactivation assays <br />                                             Host cell reactivation assays performed determine repair UV-induced DNA <br />                                             damage previously described [12]. pGL3 Firefly luciferase reporter plasmid was <br />                                             irradiated various doses UV. Saos2-TAp63&#206;&#177;, Saos2-TAp63&#206;&#178;, Saos2-TAp63&#206;&#179;, <br />                                             Saos2-TAp73&#206;&#177;, Saos2-TAp73&#206;&#178;, Saos2-TAp73&#206;&#179; cells cultured Dox (2 <br />                                             &#206;&#188;g/ml) 24 h transfected UV-irradiated plasmid. Non-irradiated pRL-SV40 <br />                                             plasmid expressing Renilla luciferase co-transfected internal control normalize <br />                                             transfection efficiency. Transfection performed using FuGENE 6 transfection <br />                                             reagent (Roche). The UV-irradiated pGL3-luciferase reporter plasmid transfected <br />                                             Saos2 H1299 cells expression plasmids TAp63&#206;&#177;, TAp63&#206;&#178; or <br />                                             TAp63&#206;&#179; (pcDNA-TAp63&#206;&#177;, pcDNA-TAp63&#206;&#178;, pcDNA-TAp63&#206;&#179;), siRNA against <br />                                             TAp63 TAp73 (Ambion). Non-irradiated pRL-SV40 plasmid co-transfected an <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             internal control. Luciferase activities measured 24 h transfection using the <br />                                             Dual-Luciferase Reporter Assay (Promega). The relative luciferase activity (i.e. <br />                                             reactivation damaged plasmids host cells) UV-treated pGL3-luciferase <br />                                             reporter plasmids expressed percentage luciferase activity untreated pGL3- <br />                                             luciferase reporter plasmids used represent capacity cells repair UV- <br />                                             induced DNA damage. <br />  <br />                                2.4. Colony formation ability assays <br />                                             Logarithmically growing cells irradiated different doses UV (0&#226;&#8364;&#8220;6 J/m2). Cells <br />                                             trypsinized UV irradiation, seeded (300&#226;&#8364;&#8220;40,000 cells/dish) culture dishes and <br />                                             cultured medium Dox (2 &#206;&#188;g/ml) weeks. Colonies fixed <br />                                             methanol, stained crystal violet, counted. Colony formation ability was <br />  <br />  <br />  <br />                                              DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                                     Page 4 <br />  <br />  <br />                                             calculated dividing plating efficiency irradiated cells non-irradiated <br />                                             control cells. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                2.5. Quantitative Taqman real-time PCR <br />                                             Total RNA extracted cells using RNeasy kit (Qiagen). The cDNA prepared <br />                                             random primers using Taqman reverse transcription kit (Applied Biosystems). Real- <br />                                             time PCR performed triplicate TaqMan PCR Mix (Applied Biosystems) using <br />                                             ABI Step One System (Applied Biosystems). All primers purchased Applied <br />                                             Biosystems. The expression target genes normalized &#206;&#178;-actin gene. <br />  <br />                                2.6. Western-blot assays <br />                                             Standard Western-blot assays used analyze protein levels cells previously <br />                                             described [13]. Anti-p63 antibody (4A4), anti-p73 antibody (H-79), anti-DDB2 antibody <br />                                             (H-127) anti-GADD45A antibody (C-4) purchased Santa Cruz <br />                                             Biotechnology. Anti-XPC antibody purchased form Gene Tex, Anti-&#206;&#178;-actin <br />                                             (A5441) purchased Sigma&#226;&#8364;&#8220;Aldrich. <br />  <br />                                2.7. Construction reporter plasmids dual-luciferase reporter assays <br />                                             The TOPO II vector (Invitrogen) used clone PCR fragments containing p53 <br />                                             binding elements human DDB2 XPC genes, respectively. The sequences the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             primers used DDB2 gene follows: 5&#226;&#8364;&#178;-GAAGGGGCGGGGTCTCCG-3&#226;&#8364;&#178; 5&#226;&#8364;&#178;- <br />                                             AGCCATCGCGTCCTCCGTGT-3&#226;&#8364;&#178;. The sequences primers XPC gene as <br />                                             follows: 5&#226;&#8364;&#178;-CGGGGTACCGGAAAAACACTCACTTAATGCCTACC-3&#226;&#8364;&#178; 5&#226;&#8364;&#178;- <br />                                             CCGCTCGAGGTTGAACCCGGACTGCCTGACT-3&#226;&#8364;&#178;. The sequences primers for <br />                                             GADD45 gene follows: 5&#226;&#8364;&#178;-CGGGGTACCGCTGGGTTGCCTGATTGTGGAT-3&#226;&#8364;&#178; <br />                                             5&#226;&#8364;&#178;-CCGCTCGAGACGGGAGGCAGTGCAGATGTAGG-3&#226;&#8364;&#178;. The sequence-confirmed <br />                                             clones subcloned pGL2-Basic luciferase reporter plasmid (Promega). For <br />                                             luciferase reporter assays, pGL2 reporter plasmids containing copy p53 <br />                                             binding element transfected Saos2 Saos2-TAp63&#206;&#179; cells pRL- <br />                                             SV40 plasmid expressing Renilla luciferase internal control normalize transfection <br />                                             efficiency. Transfection performed using FuGENE 6 transfection reagent (Roche). <br />                                             After transfection, cells cultured medium Dox (2 &#206;&#188;g/ml) 24 h. <br />                                             Cells collected luciferase activities measured using Dual- <br />                                             Luciferase Reporter Assay (Promega). The reporter activity calculated as <br />                                             luciferase activity reporter plasmids cells Dox treatment compared in <br />                                             cells Dox treatment. <br />  <br />                                2.8. Statistical analysis <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             The data expressed mean &#194;&#177; SD. Significance calculated using Student&#226;&#8364;&#8482;s <br />                                             t-test. Values p &lt; 0.05 considered significant. <br />  <br />                                3. Results <br />                                3.1. TAp63&#206;&#179; enhances repair UV-induced DNA damage <br />                                             To investigate TAp63 TAp73 isoforms regulate NER, Saos2-derived cell lines <br />                                             stably transfected Tet-on inducible TAp63 isoforms &#206;&#177;, &#206;&#178;, &#206;&#179; TAp73 isoforms &#206;&#177;, &#206;&#178;, &#206;&#179; <br />                                             (Saos2-TAp63&#206;&#177;, Saos2-TAp63&#206;&#178;, Saos2-TAp63&#206;&#179;, Saos2-TAp73&#206;&#177;, Saos2-TAp73&#206;&#178;, and <br />                                             Saos2-TAp73&#206;&#179;) employed. Saos2 cells deficient p53, p63 p73 [11]. As <br />                                             shown Fig. 1B, protein levels TAp63 TAp73 isoforms undetectable in <br />                                             cells Dox treatment, clearly induced Dox treatment (2 &#206;&#188;g/ml). The <br />                                             induction TAp63 TAp73 isoforms clearly induced expression known <br />  <br />  <br />                                              DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                           Page 5 <br />  <br />  <br />                                         target genes, Perp (induced p63) p21 (induced p73) (Fig. 1C). Among &#206;&#177;, &#206;&#178; &#206;&#179; <br />                                         isoforms TAp63 TAp73, TAp63&#206;&#179; TAp73&#206;&#179; showed strongest transcriptional <br />                                         induction target genes, consistent previous reports [1]. Saos2, Saos2- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         TAp63&#206;&#177;, Saos2-TAp63&#206;&#178;, Saos2-TAp63&#206;&#179;, Saos2-TAp73&#206;&#177;, Saos2-TAp73&#206;&#178;, Saos2- <br />                                         TAp73&#206;&#179; cells irradiated UV (20 J/m2), repair CPD NER cells <br />                                         determined employing ELISA assays specifically detect CPD levels in <br />                                         genomic DNA. In control Saos2 cells, Dox treatment did change repair CPD (data <br />                                         shown). As shown Fig. 2A, overexpression TAp63&#206;&#179; significantly increased the <br />                                         repair CPD Saos2 cells. At 6 h UV irradiation, ~50% CPDs already <br />                                         removed cells TAp63&#206;&#179; overexpression 20% CPDs repaired <br />                                         control Saos2-TAp63&#206;&#179; cells Dox treatment. Over entire 24 h, significantly <br />                                         CPDs removed cells TAp63&#206;&#179; overexpression (p &lt; 0.05). However, <br />                                         overexpression isoforms TAp63 TAp73, including TAp63&#206;&#177;, TAp63&#206;&#178;, <br />                                         TAp73&#206;&#177;, TAp73&#206;&#178;, TAp73&#206;&#179;, did clearly increase removal CPD Saos2 cells. <br />  <br />                                         The effect TAp63&#206;&#179; repair 6&#226;&#8364;&#8220;4 PP determined Saos2 cells by <br />                                         employing ELISA assays specifically detect 6&#226;&#8364;&#8220;4 PP levels genomic DNA. As <br />                                         shown Fig. 2B, overexpression TAp63&#206;&#179; significantly increased repair 6&#226;&#8364;&#8220;4 PP <br />                                         compared control Saos2-TAp63&#206;&#179; cells Dox treatment (p &lt; 0.05), whereas <br />                                         overexpression isoform TAp63 (e.g. TAp63&#206;&#177;) did increase repair 6&#226;&#8364;&#8220;4 <br />                                         PP Saos2 cells. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         To confirm TAp63&#206;&#179; involved NER, host cell reactivation assays performed <br />                                         determine impact TAp63&#206;&#179; repair UV-induced DNA damage. Saos2- <br />                                         TAp63&#206;&#179; cells cultured Dox (2 &#206;&#188;g/ml) transfected pGL3- <br />                                         luciferase reporter plasmid irradiated different doses UV. The luciferase activity was <br />                                         determined 24 h transfection. Since full-<span id='am-2' about='xsp:length' typeof='owl:Thing'>length</span> transcript produced <br />                                         unless UV-induced DNA damage repaired plasmid, luciferase activity <br />                                         reflects repair UV-induced DNA damage reporter plasmid. As shown Fig. <br />                                         3A, overexpression TAp63&#206;&#179; significantly increased relative luciferase activities the <br />                                         UV-damaged reporter plasmids (p &lt; 0.05). Host cell reactivation assays also <br />                                         determined Saos2-TAp63&#206;&#177;, Saos2-TAp63&#206;&#178;, Saos2-TAp73&#206;&#177;, Saos2-TAp73&#206;&#178;, Saos2- <br />                                         TAp73&#206;&#179; cells. Overexpression TAp63&#206;&#177;/&#206;&#178; (Fig. 3A) TAp73&#206;&#177;/&#206;&#178;/&#206;&#179; (data shown) did <br />                                         increase relative luciferase activities UV-damaged reporter plasmids. Host cell <br />                                         reactivation assays performed Saos2 cells transiently transfected UV- <br />                                         irradiated pGL3 plasmid expression plasmids TAp63&#206;&#177;, TAp63&#206;&#178; or <br />                                         TAp63&#206;&#179; (pcDNA-TAp63&#206;&#177;, pcDNA-TAp63&#206;&#178;, pcDNA-TAp63&#206;&#179;). As shown Fig. 3B, <br />                                         overexpression TAp63&#206;&#179; TAp63&#206;&#177; TAp63&#206;&#178; significantly increased relative <br />                                         luciferase activities UV-damaged pGL3 reporter plasmids. The effect TAp63&#206;&#179; on <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         repair UV-induced DNA damage confirmed H1299 cells. H1299 cells are <br />                                         p53-null cells express low levels endogenous p63 p73. H1299 cells were <br />                                         transfected UV-irradiated pGL3 reporter plasmids expression plasmids for <br />                                         TAp63&#206;&#177;, TAp63&#206;&#178;, TAp63&#206;&#179;. Over-expression TAp63&#206;&#179; TAp63&#206;&#177; TAp63&#206;&#178; <br />                                         clearly increased relative luciferase activities UV-damaged pGL3 reporter <br />                                         plasmids H1299 cells (p &lt; 0.05) (Fig. 3C). Furthermore, host cell reactivation assays were <br />                                         preformed H1299 cells knockdown endogenous TAp63 TAp73. Due to <br />                                         structural similarity isoforms p63 p73, siRNA specifically knockdown <br />                                         isoform affecting expression isoforms. Here, siRNAs targeting TA <br />                                         domain p63 p73 employed knockdown TAp63, including TAp63&#206;&#179;, TAp73. <br />                                         As shown Fig. 3D, knockdown TAp63 TAp73 clearly decreased relative <br />                                         luciferase activities UV-damaged pGL3 reporter plasmids H1299 cells (p &lt; 0.05). <br />                                         Similar results obtained sets siRNA targeting TA domain p63 p73 <br />                                         used. These results consistent results determining NER CPD genomic <br />  <br />  <br />                                         DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                                Page 6 <br />  <br />  <br />                                             DNA. Together, results clearly demonstrate TAp63&#206;&#179; enhances NER UV- <br />                                             induced DNA damage. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             It shown TAp63&#206;&#179; protein accumulates response UV irradiation or <br />                                             actinomycin D treatment mouse cells, mediated post-translational <br />                                             modification [14]. However, existence multiple isoforms p63 cells with <br />                                             close molecular weight high structure similarity, relative low levels endogenous <br />                                             TAp63&#206;&#179; protein, lack antibody specific TAp63&#206;&#179;, difficult determine <br />                                             endogenous levels TAp63&#206;&#179; cells. Therefore, induction TAp63&#206;&#179; protein by <br />                                             UV irradiation actinomycin D demonstrated induction ectopic <br />                                             overexpressed TAp63&#206;&#179; protein instead endogenous protein study [14]. <br />                                             Employing strategy, accumulation TAp63&#206;&#179; protein response UV <br />                                             irradiation observed human Saos2 cells. As shown Fig. 3E, UV irradiation <br />                                             induced accumulation TAp63&#206;&#179; protein time dependent manner Saos2-TAp63&#206;&#179; <br />                                             cells pretreated Dox (50 ng/ml 8 h); higher TAp63&#206;&#179; protein levels were <br />                                             observed Saos2-TAp63&#206;&#179; cells treated Dox UV compared cells <br />                                             treated Dox only. Furthermore, consistent previous report [14], UV- <br />                                             induced TAp63&#206;&#179; protein accumulation induction mRNA TAp63&#206;&#179; <br />                                             UV irradiation; similar mRNA levels TAp63&#206;&#179; observed Saos2-TAp63&#206;&#179; cells <br />                                             treated Dox UV cells treated Dox (Data shown). These <br />                                             results strongly suggest TAp63&#206;&#179; protein accumulated response UV, which <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             turn enhances NER UV-induced DNA damage. <br />  <br />                                3.2. TAp63&#206;&#179; increases cell survival UV irradiation <br />                                             In cell types, decrease NER capacity sensitizes cells cell death induced by <br />                                             DNA-damaging agents, including UV [15&#226;&#8364;&#8220;17]. To determine increase NER <br />                                             capacity TAp63&#206;&#179; overexpression protects cells UV-induced killing, colony <br />                                             formation ability assays employed determine cell survival response UV <br />                                             irradiation Saos2 cells. Saos2, Saos2-TAp63&#206;&#177;, Saos2-TAp63&#206;&#178;, Saos2-TAp63&#206;&#179;, Saos2- <br />                                             TAp73&#206;&#177;, Saos2-TAp73&#206;&#178;, Saos2-TAp73&#206;&#179; cells cultured Dox were <br />                                             irradiated various doses UV, colony formation abilities determined. <br />                                             As shown Fig. 4, overexpression TAp63&#206;&#179; clearly increased cell survival UV <br />                                             irradiation (p &lt; 0.05). The overexpression TAp63&#206;&#177;, TAp63&#206;&#178;, TAp73&#206;&#177;, TAp73&#206;&#178; or <br />                                             TAp73&#206;&#179; did increase cell survival UV irradiation. Furthermore, Dox treatment did <br />                                             increase cell survival UV irradiation control Saos2 cells (data shown). These <br />                                             results strongly suggest enhancement NER TAp63&#206;&#179; protects cells DNA <br />                                             damage (UV)-induced cell death. <br />  <br />                                3.3. Differential induction genes involved NER TAp63 TAp73 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             It reported p53 regulates NER transcriptional regulation group of <br />                                             genes involved NER, including DDB2, XPC GADD45 [10,18,19]. DDB2 a <br />                                             subunit UV-damaged DNA-binding protein complex. XPC NER factors. <br />                                             Both DDB2 XPC proteins localize sites UV-induced DNA lesions, including CPD, <br />                                             involved recognition DNA damage [18,20,21]. GADD45 shown <br />                                             bind UV-damaged chromatin, enhances accessibility DNA damage <br />                                             sites repair proteins [22,23]. It reported TAp63 TAp73 bind to <br />                                             similar identical p53-consensus binding elements transcriptionally regulate group of <br />                                             p53 target genes. TAp63 TAp73 multiple isoforms alternative splicing the <br />                                             carboxy-terminal end, different transcriptional activities biological <br />                                             functions. It possible TAp63&#206;&#179; transcriptionally regulate p53 <br />                                             target genes, turn regulate NER. To test possibility, transcriptional <br />                                             regulation DDB2, XPC GADD45 TAp63 TAp73 determined Saos2- <br />  <br />  <br />                                             DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                                Page 7 <br />  <br />  <br />                                            TAp63&#206;&#177;, Saos2-TAp63&#206;&#178;, Saos2-TAp63&#206;&#179;, Saos2-TAp73&#206;&#177;, Saos2-TAp73&#206;&#178;, Saos2- <br />                                            TAp73&#206;&#179; cells Dox treatment. As shown Fig. 5A, overexpression of <br />                                            TAp63&#206;&#179; clearly increased DDB2, XPC GADD45 protein levels, overexpression of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            TAp63&#206;&#178;, TAp73&#206;&#178; TAp73&#206;&#179; increased GADD45 protein levels, overexpression of <br />                                            TAp63&#206;&#177; TAp73&#206;&#177; did clear effect expression levels of these <br />                                            proteins. To test regulation DDB2, XPC GADD45 protein levels by <br />                                            TAp63 TAp73 isoforms transcriptional regulation mRNA levels, <br />                                            DDB2, XPC GADD45 mRNA levels determined above-mentioned cells by <br />                                            Taqman real-time PCR assays. As shown Fig. 5B, mRNA levels DDB2 XPC <br />                                            clearly induced overexpression TAp63&#206;&#179;, mRNA levels GADD45 <br />                                            induced overexpression TAp63&#206;&#178;, TAp63&#206;&#179;, TAp73&#206;&#178; TAp73&#206;&#179;. These results <br />                                            consistent expression changes observed protein levels. These results <br />                                            demonstrate induction DDB2, XPC GADD45 TAp63 TAp73 <br />                                            isoforms transcriptional induction genes mRNA levels. <br />  <br />                                            The induction DDB2, XPC GADD45 TAp63&#206;&#179; observed H1299 cells. <br />                                            H1299 cells transiently transfected TAp63&#206;&#179; expression plasmids (pcDNA- <br />                                            TAp63&#206;&#179;), mRNA levels DDB2, XPC GADD45 determined Taqman <br />                                            real-time PCR assays. As shown Fig. 5C, overexpression TAp63&#206;&#179; clearly increased the <br />                                            mRNA levels DDB2, XPC GADD45 H1299 cells. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            These results demonstrate TAp63 TAp73 isoforms differentially regulate the <br />                                            transcription DDB2, XPC GADD45 genes. Among isoforms, TAp63&#206;&#179; <br />                                            isoform shows clearest induction genes RNA protein levels, <br />                                            important mechanism TAp63&#206;&#179; regulates NER. <br />  <br />                                3.4. TAp63&#206;&#179; transcriptionally activates p53-consensus DNA binding elements human <br />                                DDB2, XPC GADD45 genes <br />                                            TAp63 TAp73 shown able recognize bind p53-consensus <br />                                            DNA binding elements, turn transcriptionally regulate expression group of <br />                                            p53-target genes. It shown TAp63 TAp73 DNA binding domains bind to <br />                                            p53 binding element human GADD45 gene [24]. To test TAp63&#206;&#178; and <br />                                            TAp63&#206;&#179; recognize transactivate previously described p53 binding elements in <br />                                            human DDB2, XPC GADD45 genes, DNA fragments containing copy p53- <br />                                            consensus binding elements DDB2, XPC GADD45 genes, respectively, cloned <br />                                            promoter region pGL2 fire-fly luciferase reporter plasmid luciferase <br />                                            reporter assays performed (Fig. 6A). Saos2 Saos2-TAp63&#206;&#179; cells cultured or <br />                                            Dox co-transfected luciferase reporter plasmid pRL-SV40 <br />                                            plasmid expressing Renilla luciferase internal control. As shown Fig. 6B, the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            expression TAp63&#206;&#179; induced Dox treatment Saos2-TAp63&#206;&#179; cells significantly <br />                                            increased luciferase activity reporter plasmids containing p53 binding elements <br />                                            DDB2, XPC GADD45 genes compared Saos2-TAp63&#206;&#179; cells without <br />                                            Dox treatment. In control Saos2 cells, contain Tet-on TAp63&#206;&#179; inducible <br />                                            expression plasmid, Dox treatment did induce luciferase activities. These results <br />                                            demonstrate TAp63&#206;&#179; transactivates p53 binding elements human DDB2, XPC <br />                                            GADD45 genes, induces expression genes. <br />  <br />                                4. Discussion <br />                                            The p53 family members consist transcriptional factors p53, p63 p73 [1]. These <br />                                            proteins similar structures similar biological functions. In addition, each <br />                                            distinct biological functions. p53 plays critical role tumor suppression; p53 the <br />                                            frequently mutated gene human cancers. Loss p53 functions commonly leads to <br />  <br />  <br />                                            DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                           Page 8 <br />  <br />  <br />                                         development cancers. p63 p73 play important roles development. p63 regulates <br />                                         development epithelial cell layers p73 plays important role neuronal <br />                                         development immune response [25,26]. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         p63 p73 suggested play important roles tumor prevention. <br />                                         However, precise roles p63 p73 tumor prevention well-understood. It <br />                                         reported p63+/&#226;&#710;&#8217; p73+/&#226;&#710;&#8217; mice predisposed spontaneous tumors [27]. <br />                                         p63 p73 cooperate p53 tumor suppression. p53+/&#226;&#710;&#8217; p63+/&#226;&#710;&#8217; p53+/&#226;&#710;&#8217; <br />                                         p73+/&#226;&#710;&#8217; mice higher tumor burden increased metastasis compared p53+/&#226;&#710;&#8217; <br />                                         mice [27]. However, existence complex p63 p73 isoforms, of <br />                                         opposite functions, role individual isoforms tumorigenesis been <br />                                         clearly addressed. While TAp63 TAp73 bear structural functional similarity p53, <br />                                         &#206;&#8221;Np63 &#206;&#8221;Np73 act primarily dominant-negative fashion p53, p63 and <br />                                         p73. While mutations p63 p73 genes rare tumors, altered expression <br />                                         levels different p63 p73 isoforms observed tumors. Overexpression of <br />                                         &#206;&#8221;Np63/&#206;&#8221;Np73 decrease TAp63/TAp73 observed number human <br />                                         tumors [28&#226;&#8364;&#8220;30], associated poor prognosis chemotherapeutic <br />                                         response patients [31&#226;&#8364;&#8220;34]. The roles TAp63 TAp73 iso-forms tumor prevention <br />                                         demonstrated TAp63 TAp73 <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span>knockout</span> mice [35,36]. Loss of <br />                                         TAp63 mice increased genomic instability. TAp63 deficient mice develop primary and <br />                                         metastatic tumors, including carcinomas sarcomas, shorter life span. TAp73 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         deficient mice display increased risk spontaneous carcinogen-induced tumorigenesis. <br />                                         While studies mouse models demonstrate role TAp63 TAp73 tumor <br />                                         suppression, precise roles individual TA isoforms tumor suppression been <br />                                         distinguished yet. <br />  <br />                                         Results presented study demonstrate TAp63, particularly TAp63&#206;&#179;, plays an <br />                                         important role NER maintain genomic stability prevent tumor formation. The NER <br />                                         pathway important repair mechanisms remove wide spectrum of <br />                                         different bulky DNA lesions caused UV chemical carcinogens. It well- <br />                                         documented human cells, p53 promotes NER CPD. p53 transcriptionally <br />                                         induces DDB2, XPC GADD45 genes, play important roles NER. In this <br />                                         study, Saos2 cells inducible expression specific isoforms TAp63 TAp73 were <br />                                         employed determine impacts NER underlying mechanisms. TAp63&#206;&#179; <br />                                         overexpression greatly increases removal CPD 6&#226;&#8364;&#8220;4 PP determined both <br />                                         ELISA assays directly measure levels DNA damage cells host cell <br />                                         reactivation assays, resulting increased cell survival UV damage. Other isoforms <br />                                         TAp63 (&#206;&#177;, &#206;&#178;) TAp73 (&#206;&#177;, &#206;&#178;, &#206;&#179;) exhibit clear effect NER. Our finding is <br />                                         consistent recent report Ferguson-Yates et al. showing knockdown p63 but <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         p73 siRNA impaired repair CPD human keratinocytes lacking p53, which <br />                                         suggests p63 involved NER [37]. However, study, siRNA p63 <br />                                         isoforms employed, distinguish p63 isoform(s) contributes the <br />                                         repair CPD 6&#226;&#8364;&#8220;4 PP. In study, using cell lines expression specific <br />                                         isoforms TAp63 TAp73, TAp63&#206;&#179; identified major isoform that <br />                                         regulates repair UV-induced DNA damage. Furthermore, knockdown endogenous <br />                                         TAp63 siRNA TAp63 clearly decreased NER UV-induced DNA damage in <br />                                         H1299 cells, strongly suggests TAp63&#206;&#179; natural occurring level enhances <br />                                         NER UV-induced DNA damage. The decrease TAp63, including TAp63&#206;&#179; been <br />                                         frequently observed human cancers. Our findings suggest decrease TAp63&#206;&#179; <br />                                         levels tumors impair NER contribute tumor formation. <br />  <br />                                         It reported p63 isoforms, TAp63&#206;&#179; strongest transactivation <br />                                         activity group p53 target genes [38]. Indeed, overexpression TAp63&#206;&#179; highly <br />  <br />  <br />                                         DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                                             Page 9 <br />  <br />  <br />                                           induces DDB2, XPC GADD45 mRNA protein levels. Overexpression of <br />                                           TAp63&#206;&#178;, TAp73&#206;&#178; TAp73&#206;&#179; induce GADD45 DDB2 XPC protein <br />                                           levels. These results demonstrate selective transcriptional regulation target genes by <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           different isoforms TAp63 TAp73. While DDB2, XPC GADD45 proteins all <br />                                           involved NER, transcriptional induction GADD45 protein be <br />                                           sufficient lead increased NER observed cells overexpression TAp63&#206;&#178;, <br />                                           TAp73&#206;&#178; TAp73&#206;&#179;. It shown p63 p73 regulate unique target <br />                                           genes addition p53-target genes. It possible TAp63&#206;&#179; transcriptionally <br />                                           regulates additional genes involved NER and/or cellular repair pathways. In <br />                                           addition transcriptional regulation genes involved NER, p53 protein itself has <br />                                           implicated NER interaction proteins involved NER, <br />                                           including TFIIH, helicases XPB XPD [39]. Considering structural similarity <br />                                           p53 TAp63&#206;&#179;, interesting test TAp63&#206;&#179; interact with <br />                                           proteins involved NER, contribute role TAp63&#206;&#179; NER. <br />                                           Future studies transcriptional program protein interactions TAp63&#206;&#179; help <br />                                           understand mechanisms TAp63&#206;&#179; regulates NER repair <br />                                           pathways. <br />  <br />                                Acknowledgments <br />                                           We thank Dr. Gerry Melino generous gift Saos2 cells Tet-on inducible expression TAp63 and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           TAp73 isoforms. W.H. supported grants National Institutes Health (1P30CA147892-01) and <br />                                           Department Defense (W81XWH-10-1-0435). Z.F. supported grants National Institute Health <br />                                           (1R01CA143204-01) New Jersey Commission Cancer Research. C.Z. supported postdoc grant <br />                                           New Jersey Commission Cancer Research. <br />  <br />  <br />                                Abbreviations <br />  <br />                                         TA               transactivation <br />                                         NER              nucleotide excision repair <br />                                         UV               ultraviolet <br />                                         CPD              cyclobutane pyrimidine dimer <br />                                         PR               prolin-rich <br />                                         DBD              DNA binding domain <br />                                         OD               oligomerization domain <br />                                         &#206;&#8221;N               amino-terminal truncated <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         DBS              double strand break <br />                                         6&#226;&#8364;&#8220;4 PP           6&#226;&#8364;&#8220;4 photoproduct <br />                                         XP               xeroderma pigmentosum <br />                                         Dox              doxycycline <br />  <br />                                References <br />                                           1. Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G. p63 p73, ancestors p53. Cold <br />                                              Spring Harb Perspect Biol. 2010; 2:a004887. [PubMed: 20484388] <br />                                           2. Yang A, Kaghad M, Caput D, McKeon F. On shoulders giants: p63, p73 rise p53. <br />                                              Trends Genet. 2002; 18:90&#226;&#8364;&#8220;95. [PubMed: 11818141] <br />  <br />  <br />  <br />  <br />                                              DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                                  Page 10 <br />  <br />  <br />                                         3. De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, <br />                                            Levrero M, Melino G. Two new p73 splice variants, gamma delta, different transcriptional <br />                                            activity. J Exp Med. 1998; 188:1763&#226;&#8364;&#8220;1768. [PubMed: 9802988] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         4. De Laurenzi VD, Catani MV, Terrinoni A, Corazzari M, Melino G, Costanzo A, Levrero M, Knight <br />                                            RA. Additional complexity p73: induction mitogens lymphoid cells identification of <br />                                            new splicing variants epsilon zeta. Cell Death Differ. 1999; 6:389&#226;&#8364;&#8220;390. [PubMed: <br />                                            10381648] <br />                                         5. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, Saville MK, Lane <br />                                            DP. p53 isoforms regulate p53 transcriptional activity. Genes Dev. 2005; 19:2122&#226;&#8364;&#8220;2137. <br />                                            [PubMed: 16131611] <br />                                         6. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. <br />                                            p63, p53 homolog 3q27&#226;&#8364;&#8220;29, encodes multiple products transactivating, death-inducing, <br />                                            dominant-negative activities. Mol Cell. 1998; 2:305&#226;&#8364;&#8220;316. [PubMed: 9774969] <br />                                         7. Moll UM, Slade N. p63 p73: roles development tumor formation. Mol Cancer Res. 2004; <br />                                            2:371&#226;&#8364;&#8220;386. [PubMed: 15280445] <br />                                         8. Murray-Zmijewski F, Lane DP, Bourdon JC. p53/p63/p73 isoforms: orchestra isoforms to <br />                                            harmonise cell differentiation response stress. Cell Death Differ. 2006; 13:962&#226;&#8364;&#8220;972. <br />                                            [PubMed: 16601753] <br />                                         9. Lin YL, Sengupta S, Gurdziel K, Bell GW, Jacks T, Flores ER. p63 p73 transcriptionally <br />                                            regulate genes involved DNA repair. PLoS Genet. 2009; 5:e1000680. [PubMed: 19816568] <br />                                         10. Adimoolam S, Ford JM. p53 regulation DNA damage recognition nucleotide <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              excision repair. DNA Repair (Amst). 2003; 2:947&#226;&#8364;&#8220;954. [PubMed: 12967652] <br />                                         11. Terrinoni A, Ranalli M, Cadot B, Leta A, Bagetta G, Vousden KH, Melino G. p73-alpha capable <br />                                              inducing scotin ER stress. Oncogene. 2004; 23:3721&#226;&#8364;&#8220;3725. [PubMed: 15116103] <br />                                         12. Hu W, Feng Z, Tang MS. Chromium(VI) enhances (+/&#226;&#710;&#8217;)-anti-7beta, 8alpha-dihydroxy-9alpha, <br />                                              10alpha-epoxy-7,8,9,10-tetrahydro benzo[a]pyrene-induced cytotoxicity mutagenicity in <br />                                              mammalian cells inhibitory effect nucleotide excision repair. Biochemistry. 2004; <br />                                              43:14282&#226;&#8364;&#8220;14289. [PubMed: 15518579] <br />                                         13. Hu W, Feng Z, Ma L, Wagner J, Rice JJ, Stolovitzky G, Levine AJ. A single nucleotide <br />                                              polymorphism MDM2 gene disrupts oscillation p53 MDM2 levels cells. <br />                                              Cancer Res. 2007; 67:2757&#226;&#8364;&#8220;2765. [PubMed: 17363597] <br />                                         14. Katoh I, Aisaki KI, Kurata SI, Ikawa S, Ikawa Y. p51A (TAp63gamma), p53 homolog, <br />                                              accumulates response DNA damage cell regulation. Oncogene. 2000; 19:3126&#226;&#8364;&#8220;3130. <br />                                              [PubMed: 10871867] <br />                                         15. Cistulli CA, Kaufmann WK. p53-dependent signaling sustains DNA replication enhances <br />                                              clonogenic survival 254 nm ultraviolet-irradiated human fibroblasts. Cancer Res. 1998; <br />                                              58:1993&#226;&#8364;&#8220;2002. [PubMed: 9581844] <br />                                         16. Ford JM, Baron EL, Hanawalt PC. Human fibroblasts expressing human papillomavirus E6 <br />                                              gene deficient global genomic nucleotide excision repair sensitive ultraviolet <br />                                              irradiation. Cancer Res. 1998; 58:599&#226;&#8364;&#8220;603. [PubMed: 9485006] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         17. Smith ML, Kontny HU, Zhan Q, Sreenath A, O&#226;&#8364;&#8482;Connor PM, Fornace AJ Jr. Antisense, GADD45 <br />                                              expression results decreased DNA repair sensitizes cells U.V.-irradiation cisplatin. <br />                                              Oncogene. 1996; 13:2255&#226;&#8364;&#8220;2263. [PubMed: 8950993] <br />                                         18. Hwang BJ, Ford JM, Hanawalt PC, Chu G. Expression p48 xeroderma pigmentosum gene is <br />                                              p53-dependent involved global genomic repair. Proc Natl Acad Sci USA. 1999; 96:424&#226;&#8364;&#8220; <br />                                              428. [PubMed: 9892649] <br />                                         19. Fitch ME, Cross IV, Turner SJ, Adimoolam S, Lin CX, Williams KG, Ford JM. The DDB2 <br />                                              nucleotide excision repair gene product p48 enhances global genomic repair p53 deficient <br />                                              human fibroblasts. DNA Repair (Amst). 2003; 2:819&#226;&#8364;&#8220;826. [PubMed: 12826282] <br />                                         20. Venema J, van Hoffen A, Karcagi V, Natarajan AT, van Zeeland AA, Mullenders LH. Xeroderma <br />                                              pigmentosum complementation group C cells remove pyrimidine dimers selectively the <br />                                              transcribed strand active genes. Mol Cell Biol. 1991; 11:4128&#226;&#8364;&#8220;4134. [PubMed: 1649389] <br />  <br />  <br />  <br />  <br />                                          DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                                 Page 11 <br />  <br />  <br />                                         21. Fitch ME, Cross IV, Ford JM. p53 responsive nucleotide excision repair gene products p48 and <br />                                             XPC, p53, localize sites UV-irradiation-induced DNA damage, vivo. <br />                                             Carcinogenesis. 2003; 24:843&#226;&#8364;&#8220;850. [PubMed: 12771027] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         22. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt <br />                                             PC, Fornace AJ Jr. p53-mediated DNA repair responses UV radiation: studies mouse cells <br />                                             lacking p53, p21, and/or gadd45 genes. Mol Cell Biol. 2000; 20:3705&#226;&#8364;&#8220;3714. [PubMed: 10779360] <br />                                         23. Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, <br />                                             Weinstein JN, Pommier Y, Fornace AJ Jr. Gadd45, p53-responsive stress protein, modifies DNA <br />                                             accessibility damaged chromatin. Mol Cell Biol. 1999; 19:1673&#226;&#8364;&#8220;1685. [PubMed: 10022855] <br />                                         24. Patel S, Bui TT, Drake AF, Fraternali F, Nikolova PV. The p73 DNA binding domain displays <br />                                             enhanced stability relative homologue, tumor suppressor p53, exhibits cooperative <br />                                             DNA binding. Biochemistry. 2008; 47:3235&#226;&#8364;&#8220;3244. [PubMed: 18260640] <br />                                         25. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 p53 homologue required <br />                                             limb epidermal morphogenesis. Nature. 1999; 398:708&#226;&#8364;&#8220;713. [PubMed: 10227293] <br />                                         26. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, <br />                                             Dikkes P, Sharpe A, McKeon F, Caput D. p73-deficient mice neurological, pheromonal and <br />                                             inflammatory defects lack spontaneous tumours. Nature. 2000; 404:99&#226;&#8364;&#8220;103. [PubMed: <br />                                             10716451] <br />                                         27. Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D, Yang A, McKeon F, Jacks <br />                                             T. Tumor predisposition mice mutant p63 p73: evidence broader tumor suppressor <br />                                             functions p53 family. Cancer Cell. 2005; 7:363&#226;&#8364;&#8220;373. [PubMed: 15837625] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         28. Park BJ, Lee SJ, Kim JI, Lee CH, Chang SG, Park JH, Chi SG. Frequent alteration p63 <br />                                             expression human primary bladder carcinomas. Cancer Res. 2000; 60:3370&#226;&#8364;&#8220;3374. [PubMed: <br />                                             10910040] <br />                                         29. Nylander K, Coates PJ, Hall PA. Characterization expression <span id='am-239' about='xsp:pattern' typeof='owl:Thing'>pattern</span> p63 alpha delta <br />                                             Np63 alpha benign malignant oral epithelial lesions. Int J Cancer. 2000; 87:368&#226;&#8364;&#8220;372. <br />                                             [PubMed: 10897041] <br />                                         30. Crook T, Nicholls JM, Brooks L, O&#226;&#8364;&#8482;Nions J, Allday MJ. High level expression deltaN-p63: a <br />                                             mechanism inactivation p53 undifferentiated nasopharyngeal carcinoma (NPC)? <br />                                             Oncogene. 2000; 19:3439&#226;&#8364;&#8220;3444. [PubMed: 10918601] <br />                                         31. Casciano I, Mazzocco K, Boni L, Pagnan G, Banelli B, Allemanni G, Ponzoni M, Tonini GP, <br />                                             Romani M. Expression DeltaNp73 molecular marker adverse outcome neuroblastoma <br />                                             patients. Cell Death Differ. 2002; 9:246&#226;&#8364;&#8220;251. [PubMed: 11859407] <br />                                         32. Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, Daxenbichler G, Zeimet A, <br />                                             Zeillinger R, Marth C, Moll UM. Transdominant DeltaTAp73 isoforms frequently up- <br />                                             regulated ovarian cancer. Evidence role epigenetic p53 inhibitors vivo. Cancer <br />                                             Res. 2004; 64:2449&#226;&#8364;&#8220;2460. [PubMed: 15059898] <br />                                         33. Puig P, Capodieci P, Drobnjak M, Verbel D, Prives C, Cordon-Cardo C, Di Como CJ. p73 <br />                                             Expression human normal tumor tissues: loss p73alpha expression associated with <br />                                             tumor progression bladder cancer. Clin Cancer Res. 2003; 9:5642&#226;&#8364;&#8220;5651. [PubMed: 14654547] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         34. Urist MJ, Di Como CJ, Lu ML, Charytonowicz E, Verbel D, Crum CP, Ince TA, McKeon FD, <br />                                             Cordon-Cardo C. Loss p63 expression associated tumor progression bladder cancer. <br />                                             Am J Pathol. 2002; 161:1199&#226;&#8364;&#8220;1206. [PubMed: 12368193] <br />                                         35. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, Leung ML, El-Naggar A, Creighton CJ, <br />                                             Suraokar MB, Wistuba I, Flores ER. TAp63 suppresses metastasis coordinate regulation <br />                                             Dicer miRNAs. Nature. 2010; 467:986&#226;&#8364;&#8220;990. [PubMed: 20962848] <br />                                         36. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, Khan F, Itie-Youten A, <br />                                             Wakeham A, Tsao MS, Iovanna JL, Squire J, Jurisica I, Kaplan D, Melino G, Jurisicova A, Mak <br />                                             TW. TAp73 knockout shows genomic instability infertility tumor suppressor functions. <br />                                             Genes Dev. 2008; 22:2677&#226;&#8364;&#8220;2691. [PubMed: 18805989] <br />                                         37. Ferguson-Yates BE, Li H, Dong TK, Hsiao JL, Oh DH. Impaired repair cyclobutane pyrimidine <br />                                             dimers human keratinocytes deficient p53 p63. Carcinogenesis. 2008; 29:70&#226;&#8364;&#8220;75. <br />                                             [PubMed: 17984111] <br />  <br />  <br />  <br />  <br />                                          DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                                 Page 12 <br />  <br />  <br />                                         38. Petitjean A, Ruptier C, Tribollet V, Hautefeuille A, Chardon F, Cavard C, Puisieux A, Hainaut P, <br />                                             Caron Fromentel C. Properties isoforms p63: p53-like regulation response to <br />                                             genotoxic stress cross talk DeltaNp73. Carcinogenesis. 2008; 29:273&#226;&#8364;&#8220;281. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             18048390] <br />                                         39. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans <br />                                             MK, Taffe BG, et al. p53 modulation TFIIH-associated nucleotide excision repair activity. Nat <br />                                             Genet. 1995; 10:188&#226;&#8364;&#8220;195. [PubMed: 7663514] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                       Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 1. <br />                                         The expression &#206;&#177;, &#206;&#178; &#206;&#179; isoforms TAp63 TAp73 proteins Saos2-TAp63&#206;&#177;/&#206;&#178;/&#206;&#179; <br />                                         Saos2-TAp73&#206;&#177;/&#206;&#178;/&#206;&#179; cells. (A) Schematic structure &#206;&#177;, &#206;&#178; &#206;&#179; isoforms TAp63 and <br />                                         TAp73 proteins. TA: transactivation domain; PR: prolin-rich domain, DBD: DNA binding <br />                                         domain; OD: oligomerization domain. (B) The expression &#206;&#177;, &#206;&#178;, &#206;&#179; isoforms TAp63 <br />                                         TAp73 proteins Saos2-TAp63&#206;&#177;/&#206;&#178;/&#206;&#179; Saos2-TAp73&#206;&#177;/&#206;&#178;/&#206;&#179; cells treated Dox. <br />                                         Saos2 cells, deficient p53, p63 p73, stably transfected Tet-on <br />                                         expression vectors TAp63&#206;&#177;, TAp63&#206;&#178;, TAp63&#206;&#179;, TAp73&#206;&#177;, TAp73&#206;&#178;, TAp73&#206;&#179; (Saos2- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         TAp63&#206;&#177;/&#206;&#178;/&#206;&#179; Saos2-TAp73&#206;&#177;/&#206;&#178;/&#206;&#177; cells). These 6 cell lines treated Dox (2 &#206;&#188;g/ml) <br />                                         18 24 h Western-blot assays. (C) The regulation Perp p21 &#206;&#177;, &#206;&#178; &#206;&#179; <br />                                         isoforms TAp63 TAp73, respectively, Saos2 cells. Perp p21 known target <br />                                         genes TAp63 TAp73, respectively. Saos2-TAp63&#206;&#177;/&#206;&#178;/&#206;&#179; Saos2-TAp73&#206;&#177;/&#206;&#178;/&#206;&#179; <br />                                         cells treated Dox (2 &#206;&#188;g/ml) 18 24 h. mRNA levels Perp and <br />                                         p21 determined Taqman real-time PCR assays normalized levels &#206;&#178;- <br />                                         actin cells. Data represented mean &#194;&#177; SD (n = 3). <br />  <br />  <br />  <br />  <br />                                          DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                         Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 2. <br />                                         TAp63&#206;&#179; enhances repair CPD 6&#226;&#8364;&#8220;4 PP Saos2 cells. Saos2-TAp63&#206;&#177;/&#206;&#178;/&#206;&#179; and <br />                                         Saos2-TAp73&#206;&#177;/&#206;&#178;/&#206;&#179; cells treated Dox (2 &#206;&#188;g/ml) 24 h induce expression <br />                                         &#206;&#177;, &#206;&#178;, &#206;&#179; isoforms TAp63 TAp73 proteins. Cells Dox treatment were <br />                                         used controls. Cells irradiated UV (20 J/m2), collected immediately (0 <br />                                         h) cultured fresh medium Dox (2 &#206;&#188;g/ml) different hours (4, 6, 9, 24 h) <br />                                         assays. (A) TAp63&#206;&#179; enhances repair CPD cells. The levels CPD in <br />                                         genomic DNA cells analyzed cellular CPD DNA-damage detection ELISA kit. <br />                                         (B) TAp63&#206;&#179; enhances repair 6&#226;&#8364;&#8220;4 PP cells. The levels 6&#226;&#8364;&#8220;4 PP genomic DNA <br />                                         cells analyzed cellular 6&#226;&#8364;&#8220;4 PP DNA-damage detection ELISA kit. Data are <br />                                         represented mean &#194;&#177; SD (n = 3). *p &lt; 0.05. <br />  <br />  <br />  <br />  <br />                                          DNA Repair (Amst). Author manuscript; available PMC 2013 February 01. <br />                             Liu et al.                                                                                       Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 3. <br />                                         TAp63&#206;&#179; promotes host cell reactivation UV-irradiated luciferase reporter plasmids in <br />           <br /> </body></html>